| 摘要 |
FIELD: medicine.SUBSTANCE: present group of inventions refers to medicine, namely to therapy, and concerns treating vegetative-vascular dystonia. That is ensured by administering an activated potentiated form of anti-brain specific protein S-100 antibodies in a combination with an activated potentiated form of anti-endothelial NO-synthase antibodies.EFFECT: such combined administration provides the effective treatment of vegetative-vascular dystonia by synergetic action of the administered compounds.10 cl, 16 tbl, 4 ex |
